ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

Abstract

About 50% of prostate cancers have TMPRSS2-ERG fusions with concurrent ERG overexpression. The aim of this study was to determine whether clinical differences exist between ERG-positive and ERG-negative cancers in surgically treated patients not exposed to antihormonal therapy. A secondary aim was to search for differences between these tumor classes.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer18
ISSN1078-0432
StatusVeröffentlicht - 2011
pubmed 21791629